Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Healthtrust
Julphar
McKesson
Chubb
Fuji
Chinese Patent Office
Covington
Boehringer Ingelheim
Merck

Generated: August 17, 2017

DrugPatentWatch Database Preview

ACETAZOLAMIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Acetazolamide, and when can generic versions of Acetazolamide launch?

Acetazolamide is a drug marketed by Zydus Pharms Usa Inc, Alra, Heritage Pharma, Novast Labs Ltd, Lannett, Mutual Pharm, Sun Pharm Inds, Vangard, Heritage Pharms Inc, Watson Labs, Ascot, Nostrum Labs Inc, Taro, Hospira, Par Sterile Products, Sagent Agila, X Gen Pharms, West-ward Pharms Int, and Emcure Pharms Ltd. and is included in twenty NDAs.

The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.

Summary for Tradename: ACETAZOLAMIDE

Patents:0
Applicants:19
NDAs:20
Suppliers / Packagers: see list17
Bulk Api Vendors: see list63
Clinical Trials: see list80
Patent Applications: see list4,121
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ACETAZOLAMIDE at DailyMed

Pharmacology for Tradename: ACETAZOLAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms Usa Inc
ACETAZOLAMIDE
acetazolamide
CAPSULE, EXTENDED RELEASE;ORAL040904-001Dec 10, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Sterile Products
ACETAZOLAMIDE SODIUM
acetazolamide sodium
INJECTABLE;INJECTION205358-001Jun 20, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Mutual Pharm
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL089752-001Jun 22, 1988ABRXNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharma
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL205530-002Oct 27, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Ascot
ACETAZOLAMIDE
acetazolamide
TABLET;ORAL087686-001Oct 20, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Baxter
QuintilesIMS
Deloitte
Colorcon
Teva
Harvard Business School
Citi
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot